Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon L Amidon

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Molecular Pharmaceutics|August 13, 2010
High-permeability criterion for BCS classification: segmental/pH dependent permeability considerationsArik Dahan, Jonathan M Miller, John M Hilfinger, et al.
The AAPS Journal|January 4, 2022
Dissolution Challenges Associated with the Surface pH of Drug Particles: Integration into Mechanistic Oral Absorption ModelingBart Hens, Nidhi Seegobin, Marival Bermejo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in ratLilian Y Li, Gordon L Amidon, Jae Seung Kim, et al.
Molecules (Basel, Switzerland)|August 23, 2008
Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transportersYasuhiro Tsume, Balvinder S Vig, Jing Sun, et al.
Molecular Pharmaceutics|December 19, 2017
Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of GanciclovirKefeng Sun, Hao Xu, John L Hilfinger, et al.
Molecular Pharmaceutics|April 19, 2005
A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like proteinInsook Kim, Xueqin Song, Balvinder S Vig, et al.
Molecular Pharmaceutics|April 5, 2005
Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugsSachin Mittal, Xueqin Song, Balvinder S Vig, et al.
Molecular Pharmaceutics|March 15, 2013
Cytomegalovirus protease targeted prodrug developmentHairat Sabit, Arik Dahan, Jing Sun, et al.
Molecular Pharmaceutics|December 20, 2023
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary LayerPatrick D Sinko, Niloufar Salehi, Troy Halseth, et al.
Molecular Pharmaceutics|October 8, 2013
Purely in silico BCS classification: science based quality standards for the world's drugsArik Dahan, Omri Wolk, Young Hoon Kim, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Molecular Pharmaceutics|August 13, 2010
High-permeability criterion for BCS classification: segmental/pH dependent permeability considerationsArik Dahan, Jonathan M Miller, John M Hilfinger, et al.
The AAPS Journal|January 4, 2022
Dissolution Challenges Associated with the Surface pH of Drug Particles: Integration into Mechanistic Oral Absorption ModelingBart Hens, Nidhi Seegobin, Marival Bermejo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in ratLilian Y Li, Gordon L Amidon, Jae Seung Kim, et al.
Molecules (Basel, Switzerland)|August 23, 2008
Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transportersYasuhiro Tsume, Balvinder S Vig, Jing Sun, et al.
Molecular Pharmaceutics|December 19, 2017
Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of GanciclovirKefeng Sun, Hao Xu, John L Hilfinger, et al.
Molecular Pharmaceutics|April 19, 2005
A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like proteinInsook Kim, Xueqin Song, Balvinder S Vig, et al.
Molecular Pharmaceutics|April 5, 2005
Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugsSachin Mittal, Xueqin Song, Balvinder S Vig, et al.
Molecular Pharmaceutics|March 15, 2013
Cytomegalovirus protease targeted prodrug developmentHairat Sabit, Arik Dahan, Jing Sun, et al.
Molecular Pharmaceutics|December 20, 2023
Particle Size, Dose, and Confinement Affect Passive Diffusion Flux through the Membrane Concentration Boundary LayerPatrick D Sinko, Niloufar Salehi, Troy Halseth, et al.
Molecular Pharmaceutics|October 8, 2013
Purely in silico BCS classification: science based quality standards for the world's drugsArik Dahan, Omri Wolk, Young Hoon Kim, et al.
Pageof 18